MicroRNA-27a/b mediates endothelin-1-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells

[1]  Yan-ting Zhu,et al.  Knockdown of AMPKα2 Promotes Pulmonary Arterial Smooth Muscle Cells Proliferation via mTOR/Skp2/p27Kip1 Signaling Pathway , 2016, International journal of molecular sciences.

[2]  Ming Zhao,et al.  High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer , 2016, Journal of experimental & clinical cancer research : CR.

[3]  Yan-ting Zhu,et al.  Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms. , 2016, Pharmacological research.

[4]  Fei Liu,et al.  Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells. , 2015, International journal of oncology.

[5]  Zhong-dong Hu,et al.  Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion , 2015, Oncotarget.

[6]  E. Hoffman,et al.  TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy. , 2015, Cell reports.

[7]  C. Yeh,et al.  Role of microRNAs in Vascular Remodeling , 2015, Current molecular medicine.

[8]  I. Bazan,et al.  Pulmonary hypertension: diagnostic and therapeutic challenges , 2015, Therapeutics and clinical risk management.

[9]  Yan Zeng,et al.  Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells , 2015, Scientific Reports.

[10]  Gong Cheng,et al.  Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway. , 2015, Microvascular research.

[11]  Yan-ting Zhu,et al.  Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats. , 2015, Biomedical reports.

[12]  Baofeng Yang,et al.  MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. , 2015, The international journal of biochemistry & cell biology.

[13]  Ying Ma,et al.  PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. , 2015, Biochemical and biophysical research communications.

[14]  Yang Yang,et al.  MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production. , 2015, Biochemical and biophysical research communications.

[15]  Z. Meng,et al.  Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells , 2015, PloS one.

[16]  Jing Li,et al.  MiR-27a Promotes Hepatocellular Carcinoma Cell Proliferation Through Suppression of its Target Gene Peroxisome Proliferator-activated Receptor γ , 2015, Chinese medical journal.

[17]  M. Gassmann,et al.  The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A. , 2015, The international journal of biochemistry & cell biology.

[18]  A. Chauhan,et al.  Endothelial PPAR-&ggr; Protects Against Vascular Thrombosis by Downregulating P-Selectin Expression , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[19]  B. Kang,et al.  Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation. , 2015, Free radical biology & medicine.

[20]  E. Araki,et al.  Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation. , 2015, Biochemical and biophysical research communications.

[21]  R. Kittler,et al.  An integrated functional genomic analysis identifies the antitumorigenic mechanism of action for PPARγ in lung cancer cells , 2014, Genomics data.

[22]  D. Milenkovic.  MicroRNAs as novel nutrigenomic targets for cardiovascular health. , 2014, Free radical biology & medicine.

[23]  Youwen Liu,et al.  miR-27 inhibits adipocyte differentiation via suppressing CREB expression. , 2014, Acta biochimica et biophysica Sinica.

[24]  Y. Janssen-Heininger,et al.  Inhibition of Nuclear Factor-&kgr;B in the Lungs Prevents Monocrotaline-Induced Pulmonary Hypertension in Mice , 2014, Hypertension.

[25]  Yuan-yuan Wu,et al.  Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation , 2014, Experimental lung research.

[26]  R. Vento,et al.  WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation , 2014, Apoptosis.

[27]  Lei Dong,et al.  Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats. , 2014, Life sciences.

[28]  X. Tian,et al.  Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors , 2014, PPAR research.

[29]  S. Abman,et al.  Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[30]  S. Abman,et al.  Peroxisome proliferator activated receptor-γ-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[31]  B. Kang,et al.  Hypoxia Mediates Mutual Repression between microRNA-27a and PPARγ in the Pulmonary Vasculature , 2013, PloS one.

[32]  T. Murphy,et al.  Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. , 2013, Free radical biology & medicine.

[33]  A. Itai,et al.  Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. , 2013, Cardiovascular research.

[34]  I. Ng,et al.  EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers , 2013, PloS one.

[35]  W. Kassouf,et al.  A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer , 2013, PloS one.

[36]  M. Fung,et al.  Peroxisome Proliferator-Activated Receptor-&ggr; Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor , 2012, Hypertension.

[37]  T. Sooronbaev,et al.  Bosentan reduces pulmonary artery pressure in high altitude residents. , 2012, High altitude medicine & biology.

[38]  Z. Jing,et al.  Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways , 2012, European Respiratory Journal.

[39]  B. Kang,et al.  The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. , 2012, American journal of respiratory cell and molecular biology.

[40]  E. Abraham,et al.  miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[41]  F. Fazal,et al.  Blocking NF-κB: an inflammatory issue. , 2011, Proceedings of the American Thoracic Society.

[42]  Jiarui Wu,et al.  TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. , 2011, Biochemical and biophysical research communications.

[43]  K. Kang,et al.  Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression , 2011, Cancer biology & therapy.

[44]  E. Y. Kim,et al.  Plasma C-Reactive Protein and Endothelin-1 Level in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension , 2010, Journal of Korean medical science.

[45]  J. Neuhaus,et al.  Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. , 2010, American journal of respiratory and critical care medicine.

[46]  Eun Kyung Kim,et al.  Rosiglitazone attenuates hypoxia‐induced pulmonary arterial hypertension in rats , 2010, Respirology.

[47]  M. Humbert,et al.  Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010, Circulation.

[48]  R. Khanin,et al.  Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[49]  T. Murphy,et al.  PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[50]  Zong-fang Li,et al.  Heme oxygenase‐1/p21WAF1 mediates peroxisome proliferator‐activated receptor‐γ signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells , 2010, The FEBS journal.

[51]  B. Brüne,et al.  MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization* , 2010, The Journal of Biological Chemistry.

[52]  A. Kim,et al.  miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. , 2010, Biochemical and biophysical research communications.

[53]  G. Hansmann,et al.  Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[54]  S. Safe,et al.  Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cells , 2009, International journal of cancer.

[55]  Jianping Ye,et al.  A role of miR‐27 in the regulation of adipogenesis , 2009, The FEBS journal.

[56]  Min Liu,et al.  MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. , 2009, Cancer letters.

[57]  Xiuping Liu,et al.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. , 2008, Biochemical pharmacology.

[58]  W. Frishman,et al.  Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[59]  G. Hansmann,et al.  An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. , 2008, The Journal of clinical investigation.

[60]  A. Mizoguchi,et al.  A Nuclear Factor-κB Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats , 2007 .

[61]  K. Stenmark,et al.  Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[62]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[63]  M. Wolfe,et al.  Attenuation of Peroxisome Proliferator-activated Receptor γ (PPARγ) Mediates Gastrin-stimulated Colorectal Cancer Cell Proliferation* , 2006, Journal of Biological Chemistry.

[64]  W. Su,et al.  CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway , 2005, Acta Pharmacologica Sinica.

[65]  B. Rovin,et al.  Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NFκB Signal Disruption in Human WISH and Amnion Cells1 , 2005, Biology of reproduction.

[66]  Jin Wei,et al.  [Effect of endothelin-1 stimulation on peroxisome proliferator-activated receptor-gamma expression in vascular smooth muscle cells]. , 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[67]  Satoshi Suzuki,et al.  [Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats]. , 2005, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[68]  N. Cheshire,et al.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[70]  M. Wick,et al.  Peroxisome Proliferator-Activated Receptor Gamma (PPAR&ggr;) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth , 2003, Circulation research.

[71]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[72]  P. Steendijk,et al.  Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. , 2001, Early human development.

[73]  D. Stewart,et al.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.

[74]  Fei Liu,et al.  Elevation of miR-27 b by HPV 16 E 7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells , 2015 .

[75]  A. Mizoguchi,et al.  A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. , 2007, Chest.

[76]  M. Wolfe,et al.  Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. , 2006, The Journal of biological chemistry.

[77]  S. Pettersson,et al.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.

[78]  B. Kang,et al.  Hypoxia Mediates Mutual Repression between microRNA-27a and PPAR gamma in the Pulmonary Vasculature , 2022 .

[79]  M. Fung,et al.  Peroxisome Proliferator-Activated Receptor-γ Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2 B Receptor , 2022 .